Mangoceuticals (MGRX) Competitors $2.53 +0.33 (+15.00%) Closing price 04:00 PM EasternExtended Trading$2.59 +0.06 (+2.37%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. BNR, CORBF, EUDA, PIII, ATPC, BDSX, BMGL, MRAI, CCM, and BRTXShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Burning Rock Biotech (BNR), Global Cord Blood (CORBF), EUDA Health (EUDA), P3 Health Partners (PIII), Agape ATP (ATPC), Biodesix (BDSX), Basel Medical Group (BMGL), Marpai (MRAI), Concord Medical Services (CCM), and Biorestorative Therapies (BRTX). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Burning Rock Biotech Global Cord Blood EUDA Health P3 Health Partners Agape ATP Biodesix Basel Medical Group Marpai Concord Medical Services Biorestorative Therapies Mangoceuticals (NASDAQ:MGRX) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk. Is MGRX or BNR more profitable? Burning Rock Biotech has a net margin of -26.04% compared to Mangoceuticals' net margin of -2,757.86%. Burning Rock Biotech's return on equity of -23.61% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,757.86% -85.01% -78.08% Burning Rock Biotech -26.04%-23.61%-15.73% Do analysts recommend MGRX or BNR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media prefer MGRX or BNR? In the previous week, Burning Rock Biotech had 1 more articles in the media than Mangoceuticals. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Mangoceuticals. Mangoceuticals' average media sentiment score of 0.95 beat Burning Rock Biotech's score of 0.83 indicating that Mangoceuticals is being referred to more favorably in the media. Company Overall Sentiment Mangoceuticals Positive Burning Rock Biotech Positive Which has more risk & volatility, MGRX or BNR? Mangoceuticals has a beta of 2.39, meaning that its share price is 139% more volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Do institutionals & insiders have more ownership in MGRX or BNR? 56.7% of Mangoceuticals shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, MGRX or BNR? Mangoceuticals has higher earnings, but lower revenue than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$620K43.01-$8.71M-$3.86-0.66Burning Rock Biotech$536.30M0.17-$47.49M-$1.90-4.52 SummaryBurning Rock Biotech beats Mangoceuticals on 7 of the 13 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.67M$2.62B$6.04B$10.44BDividend YieldN/A57.77%5.73%4.79%P/E Ratio-0.6622.5785.3127.07Price / Sales43.01637.36588.57190.17Price / CashN/A25.7125.7330.17Price / Book0.595.3212.666.69Net Income-$8.71M$32.98M$3.31B$276.03M7 Day Performance-1.56%0.94%-0.44%-1.13%1 Month Performance11.45%9.70%8.70%6.49%1 Year Performance-94.54%-0.42%76.70%34.41% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals1.5214 of 5 stars$2.53+15.0%N/A-95.3%$26.67M$620K-0.663BNRBurning Rock Biotech0.9563 of 5 stars$9.01-5.2%N/A+158.0%$102.23M$70.67M-4.741,390Gap DownCORBFGlobal Cord BloodN/A$0.75-25.0%N/A-40.0%$91.16M$196.12M0.001,200EUDAEUDA Health1.1298 of 5 stars$2.37+0.4%N/A-25.3%$87.69M$4.01M0.002Positive NewsGap UpPIIIP3 Health Partners2.7913 of 5 stars$9.02+1.2%$16.25+80.2%-40.6%$64.04M$1.50B-0.20500ATPCAgape ATP0.4931 of 5 stars$1.17-5.3%N/A-30.9%$61.51M$1.32M-2.8440BDSXBiodesix3.297 of 5 stars$7.30-3.2%$32.50+345.2%-78.3%$55.28M$71.32M-1.26220BMGLBasel Medical GroupN/A$1.51-3.2%N/AN/A$28.79MN/A0.0036MRAIMarpaiN/A$1.55-4.3%N/A+91.3%$28.38M$34.87M-0.59150CCMConcord Medical Services0.6896 of 5 stars$5.57-2.4%N/A-16.8%$24.75M$52.60M0.00970Gap UpHigh Trading VolumeBRTXBiorestorative Therapies2.2108 of 5 stars$1.62+5.9%N/A-1.8%$12.21M$400K-1.287 Related Companies and Tools Related Companies BNR Alternatives CORBF Alternatives EUDA Alternatives PIII Alternatives ATPC Alternatives BDSX Alternatives BMGL Alternatives MRAI Alternatives CCM Alternatives BRTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
